1Wang Y D , Hu Y ,Sun C Y ,et al. Mechanism of arsenic trioxide inhibiting angiogenesis in multiple myeloma[ J]. J Huazhong Univ Sci Technol,2006, 26 : 43 -46.
2Antony VB, Loddenkemper R, Astoul P, et al. Management of malignant pleural effusions[J]. Eur Respir J,2001, 18:402 -419.
3Wetzler M, Brady MT, Tracy E, et al. Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation [ J ]. Clin Cancer Res, 2006, 12 (22) : 6817 -6825.
4Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment[ J]. Cancer , 1981,47:207 - 214.
5Park M J, Park IC, Bae I J, et al. Tetraarsenic oxide, a navel orally administrable angiogenesis inhibitor [ J ]. Int J Oncol, 2003 (6) : 1271 - 1276.
6Stat hopoulos G T , Psallidas I , Moustaki A , et al. A cent ral role for tumor - derived monocyte chemoatt ractant protein - 1 in malignant pleural effusion[ J]. J Natl Cancer Inst ,2008,100:1464 - 1476.
